Rheumatoid Arthritis Clinical Trials in New York

Showing 1741-1760 of 1,972 trials

COMPLETED< 1 mile

Correlates and Consequences of Increased Immune Activation in Injection Drug Users

NCT01831284

The goal of this study is to learn how injection drug use may affect the immune system.

Intravenous Drug Usage

Rockefeller University201 participantsStarted Dec 2012

New York, New York, United States

COMPLETEDNA< 1 mile

Safety and Efficacy of Endotracheal Intubation Using Glidescope Video-Laryngoscope

NCT01683526

The safety and efficacy of a video-laryngoscope as a primary intubation tool in urgent endotracheal intubation of critically-ill patients has not been well-described in the literature. This study will answer whether using a VL will impact on the efficacy and safety of intubation compared with a traditional direct laryngoscopy.

Respiratory Failure

Beth Israel Medical Center117 participantsStarted Aug 2012

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia

NCT00602771

This randomized phase II trial is studying the side effects and how well giving tipifarnib together with etoposide works in treating older patients with newly diagnosed, previously untreated acute myeloid leukemia. Tipifarnib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as etoposide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving tipifarnib together with etoposide may kill more cancer cells.

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more

National Cancer Institute (NCI)84 participantsStarted Jan 2008

Atlanta, Georgia, United States • Baltimore, Maryland, United States • Ann Arbor, Michigan, United States +2 more locations

Correlates and Consequences of Increased Immune Activation in Injection Drug Users

Safety and Efficacy of Endotracheal Intubation Using Glidescope Video-Laryngoscope

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia

Rheumatoid Arthritis Trials in Other Cities

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder

Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

Study of Silodosin to Facilitate Passage of Urinary Stones

Prevent Return of Stroke Study

Improving Pain and Function in Hip Fracture

Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

Efficacy and Safety Study of an Oral Contraceptive in Healthy Females

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females

Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)

Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects

RAMP Study: A Study Comparing Two Lumbar Fusion Procedures

An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy

Other Conditions in New York